From therapeutic complexity, FDA regulatory policy changes, geopolitical shocks and an AI race, life sciences supply chain leaders are forced to rewrite their playbook to stay relevant in the era of ...
The coming year is going to see the first sweeping AI laws enter into force, with global efforts to hold tech companies accountable. MIT Technology Review’s What’s Next series looks across industries, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results